Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Treasury Shares (2024 - 2025)

Historic Treasury Shares for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $1.8 million.

  • Pyxis Oncology's Treasury Shares fell 3974.15% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 3974.15%. This contributed to the annual value of $2.5 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Pyxis Oncology reported Treasury Shares of $1.8 million as of Q3 2025, which was down 3974.15% from $1.9 million recorded in Q2 2025.
  • Pyxis Oncology's 5-year Treasury Shares high stood at $3.1 million for Q1 2024, and its period low was $1.8 million during Q3 2025.